NYSE:CO - Global Cord Blood Stock Price, Forecast & News

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

Global Cord Blood Corp (NYSE:CO) issued its quarterly earnings data on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter. Global Cord Blood had a return on equity of 10.88% and a net margin of 34.86%. View Global Cord Blood's Earnings History.

Global Cord Blood is scheduled to release their next quarterly earnings announcement on Monday, March 2nd 2020. View Earnings Estimates for Global Cord Blood.

Headlines about CO stock have been trending very negative recently, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Global Cord Blood earned a news sentiment score of -3.7 on InfoTrie's scale. They also assigned media stories about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Global Cord Blood.

Global Cord Blood saw a decline in short interest in the month of February. As of February 14th, there was short interest totalling 12,700 shares, a decline of 43.8% from the January 30th total of 22,600 shares. Based on an average daily volume of 66,800 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the shares of the stock are short sold. View Global Cord Blood's Current Options Chain.

Some companies that are related to Global Cord Blood include GS ACQUISITION /SH CL A (GSAH), Diamond Eagle Acquisition (VRT), Bain Capital Specialty Finance (BCSF), Immunovant (IMVT), AdaptHealth (AHCO), Gores Holdings III (GRSH), HAYMAKER ACQUIS/SH CL A (HYAC), Trinity Merger (TMCX), Pivotal Acquisition (PVT), FORUM MERGER II/SH CL A (FMCI), Kaleyra (KLR), ANDINA ACQUISIT/SH SH (ANDA), Opes Acquisition (OPES), Leisure Acquisition (GPAQ) and AgroFresh Solutions (AGFS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include Fate Therapeutics (FATE), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), AbbVie (ABBV), Rite Aid (RAD), NovaBay Pharmaceuticals (NBY), Galectin Therapeutics (GALT), Gilead Sciences (GILD), Intel (INTC) and Marvell Technology Group (MRVL).

Global Cord Blood's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Jayhawk Capital Management L.L.C. (9.85%), Renaissance Technologies LLC (2.56%), Athos Capital Ltd (0.05%), PEAK6 Investments LLC (0.04%) and Marshall Wace LLP (0.03%). View Institutional Ownership Trends for Global Cord Blood.

CO stock was sold by a variety of institutional investors in the last quarter, including Jayhawk Capital Management L.L.C. and PEAK6 Investments LLC. View Insider Buying and Selling for Global Cord Blood.

CO stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Athos Capital Ltd and Marshall Wace LLP. View Insider Buying and Selling for Global Cord Blood.

Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CO stock can currently be purchased for approximately $3.99.

Global Cord Blood has a market capitalization of $484.38 million and generates $147.03 million in revenue each year. Global Cord Blood employs 1,261 workers across the globe.View Additional Information About Global Cord Blood.

The official website for Global Cord Blood is http://www.globalcordbloodcorp.com/.

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected]